WNW WNW
Company Profile ↓Company Overview
WNW (WNW) is a publicly traded company listed on with a market capitalization of $8.33M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 0.0.
Recent Developments
- Dec 2024 Revenue of $158.49K (-98.6% YoY); net profit $5.11M.
- Trailing 12 Months Year-on-year growth — revenue -98.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -76.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -76.53% |
| 1 Year: | -98.56% |
Stock Price Performance
| 1 Year: | -98.53% |
| 6 Months: | -98.41% |
| 3 Months: | -31.51% |
| 1 Month: | -25.92% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)39.90 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -76.5% CAGR over 5 years.
- Trading 99.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|
| Revenue | 12.26M | 10.98M | 10.98M | 158.49K |
| Cost of Revenue | 9.42M | 9.80M | 8.39M | 91.35K |
| Gross Profit | 2.84M | 1.17M | 2.58M | 67.13K |
| Operating Expenses | 3.94M | 4.91M | 4.10M | 2.11M |
| Operating Income | -1.10M | -3.74M | -1.52M | -2.05M |
| EBITDA | -713.38K | -3.65M | -1.33M | -1.92M |
| Interest Expense | - | - | - | - |
| Pretax Income | -1.12M | -11.01M | -16.11M | 4.74M |
| Tax Provision | 0 | 211.14K | 207.24K | -372.56K |
| Net Income | -1.08M | -11.07M | -16.07M | 5.11M |
| Diluted EPS | -29.30 | -174.38 | -10,996.84 | 161.45 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|
| Total Assets | 28.29M | 38.00M | 20.58M | 60.95M |
| Current Assets | 27.99M | 29.87M | 20.39M | 60.95M |
| Cash & Equivalents | 26.63M | 23.72M | 16.06M | 43.40M |
| Inventory | 432.95K | 344.82K | 95.12K | 0 |
| Receivables | 433.00K | 4.04M | 2.87M | 0 |
| Total Liabilities | 10.66M | 17.94M | 11.57M | 1.97M |
| Current Liabilities | 3.81M | 8.35M | 7.64M | 676.16K |
| Long Term Debt | 1.86M | 7.11M | 1.41M | 1.29M |
| Total Debt | 1.92M | 7.69M | 1.97M | 1.29M |
| Total Equity | 17.63M | 20.21M | 9.41M | 59.38M |
| Shares Outstanding | 47.10K | 87.06K | 146.17K | 3.17M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|
| Operating Cash Flow | -8.69M | -5.52M | -502.83K | -13.62M |
| Investing Cash Flow | 26.42M | -25.92K | -6.93M | -943.38K |
| Financing Cash Flow | 1.11M | 2.88M | 276.79K | 45.53M |
| Capital Expenditure | -81.20K | -25.92K | -6.93M | - |
| Free Cash Flow | -8.77M | -5.55M | -7.43M | -13.62M |
| Net Change in Cash | 18.84M | -2.67M | -7.15M | 30.96M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|
| Gross Margin % | 23.2% | 10.7% | 23.5% | 42.4% |
| Operating Margin % | -9.0% | -34.1% | -13.8% | -1,291.6% |
| Net Margin % | -8.8% | -100.9% | -146.4% | 3,227.2% |
| ROE % | -6.1% | -54.8% | -170.7% | 8.6% |
| ROCE % | -4.5% | -12.6% | -11.7% | -3.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for WNW
Meiwu Technology Company Limited Announces 1-For-100 Reverse Share Split
Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ: WNW) today announced that it will effect a reverse share split of its outstanding ordinary shares, no par value (the "Ordinary Shares"), at a ratio of 1-for-100.…
BC-Most Active Stocks
Megan Holdings Ltd. 7,893,938 0.2401
Univest Securities, LLC Announces Closing of $14.0 Million Registered Direct Offering for its Client Meiwu Technology Co Ltd (NASDAQ: WNW)
New York, March 18, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registere…
Meiwu Technology Co Ltd Announces $14 Million Registered Direct Offering
Meiwu Technology Co Ltd (NASDAQ: WNW) (the "Company"), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 6,999,996 of the Company's ordinary shares, no par va…
WNW Announces Strategic AI Insights Initiative to Support Functional Skincare Product Innovation
Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ: WNW) announced today that the Company is introducing a strategic artificial intelligence ("AI") insights initiative as part of its ongoing efforts to enhance research colla…
Meiwu Technology Co., Ltd. Announces MOU with Real BioTech (Qingdao) Ltd.
Xiamen, China, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Ltd. (hereinafter referred to as " Meiwu" or the "Company") (NASDAQ: WNW), a leading integrated platform in the beauty industry, announced that the Company signed a non-…
WNW — Frequently Asked Questions
What is the current share price of WNW?
As of 2026-08-05 17:25 PDT, WNW trades at $2.63 on NASDAQ/NYSE. Its 52-week range is $2.41 to $280.40.
What is the market capitalisation of WNW?
WNW has a market capitalisation of $8.33M on NASDAQ/NYSE.
What is the P/E ratio of WNW?
WNW trades at a trailing price-to-earnings (P/E) ratio of 0.02. Its price-to-book (P/B) ratio is 0.14.
What is the return on equity (ROE) of WNW?
WNW has a return on equity (ROE) of 8.61%. Its return on capital employed (ROCE) is -3.40%.
Is WNW a good stock to buy?
This page provides a data-driven analysis of WNW, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.